A New Screening Strategy for 2019 Novel Coronavirus Infection
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04281693|
Recruitment Status : Unknown
Verified February 2020 by Affiliated Hospital to Academy of Military Medical Sciences.
Recruitment status was: Not yet recruiting
First Posted : February 24, 2020
Last Update Posted : February 24, 2020
- Study Details
- Tabular View
- No Results Posted
- How to Read a Study Record
|Condition or disease||Intervention/treatment||Phase|
|Novel Coronavirus Infection Pneumonia||Diagnostic Test: Standard screening strategy Diagnostic Test: New screening strategy||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||230 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Identification of a New Screening Strategy for 2019 Novel Coronavirus Infection|
|Estimated Study Start Date :||February 2020|
|Estimated Primary Completion Date :||March 2020|
|Estimated Study Completion Date :||March 2020|
|Experimental: Screening participants||
Diagnostic Test: Standard screening strategy
The pharyngeal swab specimen was obtained and sent for NCIP RNA detection by individual testing.
Diagnostic Test: New screening strategy
The pharyngeal swab specimen was obtained and sent for NCIP RNA detection by minipool testing.
- Screening accuracy [ Time Frame: 1 month ]The screening accuracy of the two screening strategies were calculated and compared.
- Cost-effectiveness analysis [ Time Frame: 1 month ]The costs of the two screening strategies were recorded. Cost-effectiveness analysis were performed and compared.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||Child, Adult, Older Adult|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||Yes|
- Who agree to participate in the study and sign written informed consent
- Confirmed NCIP patients
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04281693
|Contact: Xiaotian Sunfirstname.lastname@example.org|
|Contact: Zheng Luemail@example.com|
|the Fifth Medical Center of Chinese PLA General Hospital|
|Beijing, Beijing, China, 100071|
|Contact: Yan Liu, Ph.D. 010-66947473 firstname.lastname@example.org|
|Principal Investigator:||Yan Liu||Beijing 302 Hospital|
|Responsible Party:||Affiliated Hospital to Academy of Military Medical Sciences|
|Other Study ID Numbers:||
|First Posted:||February 24, 2020 Key Record Dates|
|Last Update Posted:||February 24, 2020|
|Last Verified:||February 2020|
|Studies a U.S. FDA-regulated Drug Product:||No|
|Studies a U.S. FDA-regulated Device Product:||No|
Respiratory Tract Infections
Respiratory Tract Diseases
RNA Virus Infections